A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma. [electronic resource]
- Cancer research Sep 2007
- 7960-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0008-5472
10.1158/0008-5472.CAN-07-2154 doi
Antineoplastic Combined Chemotherapy Protocols--therapeutic use Cell Cycle--drug effects Drug Evaluation, Preclinical Drug Synergism ErbB Receptors--antagonists & inhibitors Erlotinib Hydrochloride Furans--administration & dosage Glioma--drug therapy Humans PTEN Phosphohydrolase--genetics Phosphoinositide-3 Kinase Inhibitors Protein Kinases--drug effects Pyridines--administration & dosage Pyrimidines--administration & dosage Quinazolines--administration & dosage TOR Serine-Threonine Kinases Treatment Outcome Tumor Cells, Cultured